{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:34:21Z","timestamp":1785198861676,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1053\/j.ajkd.2014.04.016","type":"journal-article","created":{"date-parts":[[2014,5,16]],"date-time":"2014-05-16T00:02:03Z","timestamp":1400198523000},"page":"495-498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Dual Role of Circulating Angiopoietin-Like 4 (ANGPTL4) in Promoting Hypertriglyceridemia and Lowering Proteinuria in Nephrotic Syndrome"],"prefix":"10.1053","volume":"64","author":[{"given":"Nosratola D.","family":"Vaziri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1053\/j.ajkd.2014.04.016_bib1","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJM199008303230905","article-title":"Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome","volume":"323","author":"Joven","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.ajkd.2014.04.016_bib2","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1046\/j.1523-1755.1999.07105.x","article-title":"New insights into lipid metabolism in the nephrotic syndrome","volume":"71","author":"Kaysen","year":"1999","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/j.ajkd.2014.04.016_bib3","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1046\/j.1523-1755.2003.00941.x","article-title":"Molecular mechanisms of lipid disorders in nephrotic syndrome","volume":"63","author":"Vaziri","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2014.04.016_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3396","article-title":"Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome","volume":"20","author":"Clement","year":"2014","journal-title":"Nat Med"},{"key":"10.1053\/j.ajkd.2014.04.016_bib5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1523-1755.2002.00104.x","article-title":"Downregulation of lipoprotein lipase and VLDL receptor in rats with focal glomerulosclerosis","volume":"61","author":"Sato","year":"2002","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2014.04.016_bib6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0022-2143(97)90038-X","article-title":"Gene expression of lipoprotein lipase in experimental nephrosis","volume":"130","author":"Liang","year":"1997","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1053\/j.ajkd.2014.04.016_bib7","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s10157-011-0549-3","article-title":"Lipoprotein lipase deficiency in chronic kidney disease is compounded by downregulation of endothelial GPIHBP1 expression","volume":"16","author":"Vaziri","year":"2012","journal-title":"Clin Exp Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2014.04.016_bib8","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1038\/ki.1997.263","article-title":"Down-regulation of hepatic lipase expression in experimental nephrotic syndrome","volume":"51","author":"Liang","year":"1997","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2014.04.016_bib9","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/ki.1997.242","article-title":"Acquired VLDL receptor deficiency in experimental nephrosis","volume":"51","author":"Liang","year":"1997","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2014.04.016_bib10","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/ki.1996.388","article-title":"Downregulation of hepatic LDL receptor expression in experimental nephrosis","volume":"50","author":"Vaziri","year":"1996","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2014.04.016_bib11","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1046\/j.1523-1755.2003.00911.x","article-title":"Molecular mechanism of altered cholesterol metabolism in focal glomerulosclerosis","volume":"63","author":"Vaziri","year":"2003","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2014.04.016_bib12","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1053\/j.ajkd.2013.10.042","article-title":"Plasma PCSK9 in nephrotic syndrome and in peritoneal dialysis: a cross-sectional study","volume":"63","author":"Jin","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2014.04.016_bib13","doi-asserted-by":"crossref","first-page":"F823","DOI":"10.1152\/ajprenal.2001.280.5.F823","article-title":"Acquired lecithin: cholesterol acyltransferase (LCAT) deficiency in nephrotic syndrome","volume":"49","author":"Vaziri","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1053\/j.ajkd.2014.04.016_bib14","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1046\/j.1523-1755.1999.00585.x","article-title":"Downregulation of hepatic high-density lipoprotein receptor, SR-B1 in nephrotic syndrome","volume":"56","author":"Liang","year":"1999","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ajkd.2014.04.016_bib15","first-page":"524","article-title":"Upregulation of hepatic HDL endocytic receptor and PDZK-1 dependent downregulation of HDL docking receptor in nephrotic syndrome","volume":"103","author":"Vaziri","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"10.1053\/j.ajkd.2014.04.016_bib16","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1161\/01.ATV.17.11.2559","article-title":"Role of lipoprotein-bound NEFAs in enhancing the specific activity of plasma CETP in the nephrotic syndrome","volume":"17","author":"Braschi","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"10.1053\/j.ajkd.2014.04.016_bib17","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0022-2275(20)41339-2","article-title":"Increased concentration of plasma cholesteryl ester transfer protein in nephrotic syndrome: role in dyslipidemia","volume":"33","author":"Moulin","year":"1992","journal-title":"J\u00a0Lipid Res"},{"key":"10.1053\/j.ajkd.2014.04.016_bib18","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1046\/j.1523-1755.2002.00319.x","article-title":"Upregulation of acyl-coenzyme A: cholesterol acyltransferase (ACAT) in nephrotic syndrome","volume":"61","author":"Vaziri","year":"2002","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2014.04.016_bib19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1161\/01.CIR.0000136023.70841.0F","article-title":"Acyl-CoA cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, LCAT, SRB-1 and LDL receptor deficiencies in nephrotic syndrome","volume":"110","author":"Vaziri","year":"2004","journal-title":"Circulation"},{"key":"10.1053\/j.ajkd.2014.04.016_bib20","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1523-1755.2004.00724.x","article-title":"Upregulation of hepatic acyl CoA diglycerol acyltransferase (DGAT)-1 expression in nephrotic syndrome","volume":"66","author":"Vaziri","year":"2004","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2014.04.016_bib21","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1523-1755.2004.00737.x","article-title":"Lipoprotein(a) and low-density lipoprotein-derived cholesterol in nephrotic syndrome: impact on lipid-lowering therapy?","volume":"66","author":"Kronenberg","year":"2004","journal-title":"Kidney Int"},{"issue":"9","key":"10.1053\/j.ajkd.2014.04.016_bib22","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/ki.2012.244","article-title":"Proteinuria decreases tissue lipoprotein receptor levels resulting in altered lipoprotein structure and increasing lipid levels","volume":"82","author":"Wang","year":"2012","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2014.04.016_bib23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1042\/BSR20110102","article-title":"Angiopoietin-like 4: a decade of research","volume":"32","author":"Zhu","year":"2012","journal-title":"Biosci Rep"},{"key":"10.1053\/j.ajkd.2014.04.016_bib24","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.bbrc.2009.12.145","article-title":"The acute phase response stimulates the expression of angiopoietin like protein 4","volume":"391","author":"Lu","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1053\/j.ajkd.2014.04.016_bib25","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1194\/jlr.M900145-JLR200","article-title":"GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3\u00a0and angiopoietin-like 4","volume":"50","author":"Sonnenburg","year":"2009","journal-title":"J\u00a0Lipid Res"},{"key":"10.1053\/j.ajkd.2014.04.016_bib26","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1194\/jlr.P015867","article-title":"Serum angiopoietin-like 4 protein levels and expression in adipose tissue are inversely correlated with obesity in monozygotic twins","volume":"52","author":"Robciuc","year":"2011","journal-title":"J\u00a0Lipid Res"},{"key":"10.1053\/j.ajkd.2014.04.016_bib27","doi-asserted-by":"crossref","first-page":"29469","DOI":"10.1074\/jbc.M110.142018","article-title":"Transcriptional profiling identifies functional interactions of TGF\u03b2 and PPAR\u03b2\/\u03b4 signaling: synergistic induction of ANGPTL4 transcription","volume":"285","author":"Kaddatz","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1053\/j.ajkd.2014.04.016_bib28","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/ndt\/gfr240","article-title":"Protective effects of PPARgamma agonist in acute nephrotic syndrome","volume":"27","author":"Zuo","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2014.04.016_bib29","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1038\/sj.ki.5000336","article-title":"Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis","volume":"69","author":"Yang","year":"2006","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2014.04.016_bib30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nm.2261","article-title":"Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome","volume":"17","author":"Clement","year":"2011","journal-title":"Nat Med"},{"key":"10.1053\/j.ajkd.2014.04.016_bib31","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1053\/j.ajkd.2011.07.024","article-title":"New insights into human minimal change disease: lessons from animal models","volume":"59","author":"Chugh","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2014.04.016_bib32","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1093\/ndt\/gfr096","article-title":"Effects and mechanisms of angiotensin II receptor blockade with telmisartan in a normotensive model of mesangioproliferative nephritis","volume":"26","author":"Villa","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2014.04.016_bib33","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1152\/ajprenal.00099.2005","article-title":"Dyslipidemia of chronic renal failure: the nature, mechanisms and potential consequences","volume":"290","author":"Vaziri","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1053\/j.ajkd.2014.04.016_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1542-4758.2006.01168.x","article-title":"Mechanisms of dyslipidemia of chronic renal failure","volume":"10","author":"Vaziri","year":"2006","journal-title":"Hemodial Int"},{"key":"10.1053\/j.ajkd.2014.04.016_bib35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/s-0030-1267917","article-title":"Serum levels of the adipokine fasting-induced adipose factor\/angiopoietin-like protein 4 depend on renal function","volume":"43","author":"Baranowski","year":"2011","journal-title":"Horm Metab Res"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638614007987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638614007987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:26:07Z","timestamp":1759458367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638614007987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0272638614007987"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2014.04.016","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual Role of Circulating Angiopoietin-Like 4 (ANGPTL4) in Promoting Hypertriglyceridemia and Lowering Proteinuria in Nephrotic Syndrome","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2014.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}